DocGo Inc. (DCGO)
NASDAQ: DCGO
· Real-Time Price · USD
1.27
-0.01 (-0.78%)
At close: Oct 03, 2025, 3:59 PM
1.27
0.00%
After-hours: Oct 03, 2025, 07:05 PM EDT
DocGo Revenue Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|---|---|---|---|
Mobile Health Services Segment Revenue | 30.78M | 45.21M | 71.78M | 90.66M | 116.74M | 143.94M | 139.34M | 80.06M |
Mobile Health Services Segment Revenue Growth | -31.91% | -37.02% | -20.83% | -22.34% | -18.90% | +3.30% | +74.04% | n/a |
Transportation Services Segment Revenue | 49.64M | 50.82M | 49.05M | 48.02M | 48.21M | 48.15M | 47.21M | 45.42M |
Transportation Services Segment Revenue Growth | -2.34% | +3.61% | +2.15% | -0.39% | +0.13% | +1.98% | +3.94% | n/a |
Revenue by Geography
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|---|---|---|---|---|
United Kingdom Revenue | 14.16M | 14.06M | 15.37M | 15.26M | 14.16M | 12.98M | 27.04M | 12.48M | 12.88M |
United Kingdom Revenue Growth | +0.71% | -8.54% | +0.76% | +7.73% | +9.13% | -52.01% | +116.74% | -3.16% | n/a |
United States Revenue | 66.26M | 81.97M | 105.46M | 123.43M | 150.79M | 179.11M | 285.21M | 174.08M | 112.6M |
United States Revenue Growth | -19.17% | -22.27% | -14.56% | -18.14% | -15.81% | -37.20% | +63.84% | +54.59% | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 31,609.2B | 37.44M | 40.96M | 32.46M | 39.16M | 44.83M | 47.21M | 38.77M | 33.89M | 33.17M | 37.3M | 24.48M | 28.7M | 26.47M | 30.64M | 21.42M | 18.34M | 13.54M | 12.87M | 9.55M | 8.82M | 8.27M |
Selling, General, and Administrative Revenue Growth | +84415700.11% | -8.59% | +26.20% | -17.10% | -12.66% | -5.04% | +21.77% | +14.41% | +2.18% | -11.07% | +52.37% | -14.71% | +8.43% | -13.63% | +43.06% | +16.78% | +35.52% | +5.14% | +34.75% | +8.26% | +6.68% | n/a |
Research and Development Revenue | 2,957.2B | 3.64M | 3.69M | 3.15M | 2.37M | 2.39M | 3.19M | 3.24M | 2.57M | 1.86M | 1.72M | 1.37M | 1.15M | 1.14M | 1.34M | 854.62K | 664.88K | 569.35K | 569.53K | 309.26K | 118.84K | 63.62K |
Research and Development Revenue Growth | +81254152.02% | -1.25% | +17.16% | +32.79% | -0.83% | -25.01% | -1.54% | +25.67% | +38.14% | +8.25% | +25.37% | +19.58% | +0.57% | -14.74% | +56.71% | +28.54% | +16.78% | -0.03% | +84.16% | +160.22% | +86.82% | n/a |
Sales and Marketing Revenue | 368.21B | 331.7K | 396.83K | 379.78K | 392.28K | 337.01K | 203.55K | 1.61M | 685.39K | 307.25K | 2.41M | 90.86K | 1M | 1.26M | 1.73M | 994.4K | 1.19M | 842.86K | 323.37K | 189.66K | 37.35K | 193.13K |
Sales and Marketing Revenue Growth | +111006366.59% | -16.41% | +4.49% | -3.19% | +16.40% | +65.57% | -87.32% | +134.26% | +123.07% | -87.23% | +2548.42% | -90.92% | -20.50% | -27.23% | +73.85% | -16.39% | +41.11% | +160.65% | +70.50% | +407.84% | -80.66% | n/a |